Filetype
MultiPark and Clinical Studies Sweden – Forum South, Medical Statistics and Epidemiology Unit have entered into an agreement for ongoing project support. Scientists linked to MultiPark can now turn to Medical Statistics and Epidemiology Unit for help with study design, randomization, selection of appropriate statistical analysis, implementation of analysis, reporting and interpretation of results
https://www.multipark.lu.se/infrastructures/statistical-support - 2025-07-01
This group focuses on developing new imaging-based biomarkers for monitoring the early phases of neurodegenerative processes and, potentially, the response to disease-modifying treatments. We combine multiple modalities, including MRI, PET, fluid-based markers and genetics, to clarify the biological processes leading to neurodegenerative conditions. Additionally, we leverage data from deeply pheno
The drug candidate screening platform support researchers to identify and develop novel chemical tools to help you interrogate your particular field of interest. We contribute with +30 years of combined experiences from the pharmaceutical industry.Services providedConsultations within medicinal chemistry, chemical biology and drug discovery and developmentSmall molecule screening - assay developme
https://www.multipark.lu.se/infrastructures/drug-candidate-screening-platform - 2025-07-01
Validation of presumed mechanisms of action of drug candidates using multiple methods. Functional analyses are performed at the following levels: (i) cellular calcium imaging, neuronal survival and protein aggregation assays; (ii) behavioral tests in rodents; (iii) classical biochemistry methods and MS imaging.For advanced mechanistic and functional studies of drug effects, novel state-of-the-art
https://www.multipark.lu.se/infrastructures/functional-validation-tpg - 2025-07-01
This group brings together researchers who want to use modern visualising methods to investigate molecular mechanisms at the sub-cellular level in neurodegenerative disorders. This includes, for example, high resolution, sub-cellular x-ray measurements to study molecular changes in cells or tissues to help identify the causes of the neurodegenerative diseases. MAXIV offers new techniques to unrave
https://www.multipark.lu.se/maxiv-sub-cellular-x-ray - 2025-07-01
Two-photon microscopy is the method of choice for imaging living cells and tissues (intravital microscopy). It allows imaging with very high temporal and spatial resolution in thick biological material. This MultiPark platform consists of two microscopy stations that serve different needs. The ‘in vivo’ setup can be used to image the processes in the living mouse, i.e. superficial layers of the ce
https://www.multipark.lu.se/infrastructures/two-photon-microscopy - 2025-07-01
Page under construction. Contact
https://www.multipark.lu.se/light-sheet-microscope - 2025-07-01
The Faculty of Medicine research and travel grantsTwo calls per year, see deadlines for submission on their website.The Swedish Parkinson FoundationTwo calls per year, see deadlines for submission on their website.The Royal Physiographic Society in LundSee deadlines for submission on their website.Wenner-Gren StiftelsernaTwo calls per year, see deadlines for submission on their website.Search for
https://www.multipark.lu.se/other-sources-funding-travel-grants - 2025-07-01
The “In vivo Brain Circuit Analysis” platform is a research infrastructure devoted to integrating methods and techniques to interrogate neuronal circuits in health and disease using advanced methods for the perturbation and recording of cell activity. If you are interested in using the platform contact: andreas.heuer@med.lu.se Currently we have the following equipment available for users:1) Equipt
https://www.multipark.lu.se/infrastructures/vivo-brain-circuit-analysis - 2025-07-01
Our overarching research goal is to create new and innovative strategies for improved and novel treatments, disease modifications and eventually cures for neurodegenerative diseases. We are striving to understand the mechanisms of neurodegenerative diseases, and to create a dynamic structure for the advancement of research, innovation and education in the field. Ultimately, our research will impro
https://www.multipark.lu.se/research - 2025-07-01
Welcome to the Microscopy Platform! This platform consists of four systems under one umbrella platform.Below is an overview of the systems included in this platform as well as links to their webpages with more information:SystemTarget purposeLocationImaris SingleFull with Clearview version 10.2 (Workstation)3D/4D image visualization and analysisBMC B1155Leica SP8 laser scanning confocal microscope
https://www.multipark.lu.se/infrastructures/microscopy-platform - 2025-07-01
Now available within MultiPark is a Zeiss Axio Imager M2 system, which has been brought into the environment with the intention of serving as a large image acquisition system. It is capable of bright-field and fluorescence illumination.The microscope is an upright system with a motorized stage, capable of taking both large, stitched images and Z-stacks. It is also equipped with a Zeiss ApoTome 2,
https://www.multipark.lu.se/infrastructures/microscopy-platform/zeiss-axio-imager-m2 - 2025-07-01
Course title: VMFP09 Advanced Neuroscience (30 credits)Course language: EnglishCourse venue: Lund University Medical Faculty, Biomedical Centre (BMC), Sölvegatan 19, Lund, Sweden.Course aim: The aim of the course is to acquire in-depth theoretical and practical knowledge in the subject of neuroscience, from basic neuroscientific concepts to preclinical and clinical applications. In addition, the
https://www.multipark.lu.se/lund-university-lu-neuroscience-graduate-school/advanced-neuroscience-course - 2025-07-01
Lund University is part of The European University Alliance for Global Health (EUGLOH), which is a strategic partnership between nine universities in the context of the European Commission’s European Universities Initiative.The Strategic Research Area (SRA) of Neuroscience (MultiPark, Lund University) is in the planning phase of arranging a digital EUGLOH winter course. The tentative course title
https://www.multipark.lu.se/lund-university-lu-neuroscience-graduate-school/eugloh-winter-course - 2025-07-01
This group focuses on unravelling the role of neuroinflammation in neurodegenerative diseases, to better understand disease progression and to find new strategies for better treatments. Different aspects of neuroinflammation can be studied under the microscope. Here, astrocytes (red) and microglial (green) cells approach a plaque (blue) in an experimental model of Alzheimer's disease. Photo: Yiyi
https://www.multipark.lu.se/neuroinflammatory-pathways-neurodegenerative-diseases-0 - 2025-07-01
This SIG targets digital tools that measures cognitive and motor symptoms in Alzheimer´s disease and Parkinson’s disease. We are specifically interested in their diagnostic and prognostic values, the ability to track disease progression and to detect effects of interventional studies as well as their implementation in clinical practice. A wide variety of digital tools can be used to monitor sympto
https://www.multipark.lu.se/digital-tools-reliably-evaluate-cognitive-and-neurological-symptoms - 2025-07-01
This group focuses on investigating the potential of reprogramming cells for modeling and cell replacement therapies in neurodegenerative disorders. Cellular reprogramming can directly convert cells, such as skin cells, into different types of brain cells for studying and treating neurodegenerative disorders. Illustration: Cathrine Ahlenius. We use cellular reprogramming to convert resident brain
https://www.multipark.lu.se/cellular-reprogramming-neurodegenerative-disease-modeling-diagnostics-and-repair - 2025-07-01
This group focuses on fostering translational pharmacological projects, all the way from an initial discovery in experimental models to clinical studies. Drug development requires a translational approach, from molecular investigations in cell cultures and animal models of neurodegenerative disorders to clinical trials involving patients. Illustration created with Biorender. This special interest
https://www.multipark.lu.se/regenerative-pharmacology - 2025-07-01
Multidisciplinary neuroresearch on Parkinson’s and Alzheimer’s disease How we aim to understand, treat, and cure Over 40 research groups with complementary expertise Our core comprises experimental, clinical, and health science researchers Special interest groups, from molecule to patient Senior and junior researchers meet for scientific discussions and to envision new collaborative initiatives So
https://www.multipark.lu.se/multipark - 2025-07-01
Multidisciplinary Neuroresearch on Parkinson´s and Alzheimer´s Multidisciplinary research on neurodegenerative diseases and related brain disorders with the aim to better understand, treat, and cure. Our rootsMultiPark means “Multidisciplinary research focused on Parkinson´s disease” Building on a tradition of excellence in dopamine research at Lund University, MultiPark originally focused exclusi
https://www.multipark.lu.se/about-multipark-future-page-2025 - 2025-07-01
